Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms 2024-08-29 20:42
Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results 2024-08-29 14:31
LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital 2024-08-29 10:00
Necessary Care or Abuse? Unpacking the Reason Behind Overprescription 2024-08-29 08:30
Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024 2024-08-29 08:00
Akeso's 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization 2024-08-29 04:20
Asieris Pharmaceuticals Releases 2024 Semi-Annual Report, Highlighting Steady Progress in Launching Blockbuster Product for Precancerous Cervical Lesions and Continued Strengthening of Commercial Revenue Generation Capabilities 2024-08-28 21:34
Innovent Announces 2024 Interim Results and Business Updates 2024-08-28 18:42
Tigermed Reports 2024 Interim Results 2024-08-28 18:26
Fosun Pharma Announces 2024 Interim Results 2024-08-28 18:10
Harbour BioMed Announces 2024 Interim Results 2024-08-28 17:44
Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization 2024-08-28 17:29
Yunovia Announces IND Approval by the MFDS to Initiate Phase 1 MAD Study for the Small Molecule GLP-1 Agonist 2024-08-28 10:43
Everest Medicines Announces Interim Results for First Half of 2024 2024-08-28 08:00
Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent 2024-08-28 07:53
Unique International Collaboration Brings Breakthrough Oral Cholera Vaccine to Market 2024-08-28 00:00
Boan Biotech Announces 2024 Half Year Results: Revenue Grows by 39%, Net Profit Increases by RMB 180 Million 2024-08-27 22:55
GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering New Hope for Multiple Myeloma Patients 2024-08-27 22:28
Keymed Biosciences Announces Interim Results for First Half of 2024 2024-08-27 21:10
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study 2024-08-27 20:05
1 16 17 18 19 20 412